Treatment of postmenopausal osteoporosis
- PMID: 12919968
- PMCID: PMC1126779
- DOI: 10.1136/bmj.327.7411.355
Treatment of postmenopausal osteoporosis
Comment in
-
Non-pharmacological options may have role in postmenopausal osteoporosis.BMJ. 2003 Nov 1;327(7422):1051. doi: 10.1136/bmj.327.7422.1051. BMJ. 2003. PMID: 14593067 Free PMC article. No abstract available.
Similar articles
-
Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology.Endocr Rev. 2002 Aug;23(4):496-507. doi: 10.1210/er.2001-1002. Endocr Rev. 2002. PMID: 12202464 Review. No abstract available.
-
Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.Can Fam Physician. 1998 Feb;44:327-32. Can Fam Physician. 1998. PMID: 9512836 Free PMC article.
-
Relationship between osteoporosis and cardiovascular disease in postmenopausal women.J Bone Miner Res. 2005 Nov;20(11):1912-20. doi: 10.1359/JBMR.050711. Epub 2005 Jul 18. J Bone Miner Res. 2005. PMID: 16234963
-
Postmenopausal osteoporosis treatment guidelines.Aust Fam Physician. 2000 Aug;29(8):751-3, 756-8. Aust Fam Physician. 2000. PMID: 10958021 Review.
-
[Treatment of postmenopausal osteoporosis].An Sist Sanit Navar. 2003;26 Suppl 3:91-8. An Sist Sanit Navar. 2003. PMID: 14716361 Review. Spanish.
Cited by
-
Intravenous ibandronate in the treatment of osteoporosis: profile report.Drugs Aging. 2006;23(12):997-1001. doi: 10.2165/00002512-200623120-00006. Drugs Aging. 2006. PMID: 17154663 No abstract available.
-
Zoledronic acid: a review of its use in the treatment of osteoporosis.Drugs Aging. 2008;25(11):963-86. doi: 10.2165/0002512-200825110-00007. Drugs Aging. 2008. PMID: 18947264 Review.
-
Effects of Yogasanas on osteoporosis in postmenopausal women.Int J Yoga. 2016 Jan-Jun;9(1):44-8. doi: 10.4103/0973-6131.171717. Int J Yoga. 2016. PMID: 26865770 Free PMC article.
-
Intravenous ibandronate: in the treatment of osteoporosis.Drugs. 2006;66(12):1593-601; discussion 1602-3. doi: 10.2165/00003495-200666120-00005. Drugs. 2006. PMID: 16956306 Review.
-
Non-pharmacological options may have role in postmenopausal osteoporosis.BMJ. 2003 Nov 1;327(7422):1051. doi: 10.1136/bmj.327.7422.1051. BMJ. 2003. PMID: 14593067 Free PMC article. No abstract available.
References
-
- Cummings SR, Melton LJ III. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359: 1761-7. - PubMed
-
- Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992;2: 285-9. - PubMed
-
- Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322: 801-9. - PubMed
-
- Delmas PD. Treatment of postmenopausal osteoporosis. Lancet 2002;359: 2018-26. - PubMed
-
- Hauselmann HJ, Rizzoli R. A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos Int 2003;14: 2-12. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources